Sterling Medical Devices Aims to Improve Speed to Market Amid Changing Regulatory Landscape

person using a spectrum analyzer

person using a spectrum analyzer

COVID-19 compacted a lifetime of change into a few short months, spurring immense disruption within the medtech and biotech sectors. Fold rising chronic disease and global demand for personalized care into the mix, and the healthcare system is facing mounting challenges.

Today, more than a year since the pandemic’s start, we’re at the dawn of a new era of digital and data-driven devices that make up a connected health ecosystem. In early 2020, 80% of physicians in the United States did not interact with their patients in a virtual setting. Six months later, 95% had increased their use of virtual technology. Such rapid adoption of new technology at scale comes with supply chain challenges, evolving regulations, and a myriad of new barriers to address.

Continue to full article.

Need help with your medical device?

Let Vantage MedTech show how to bring your idea from concept to prototype to FDA/CE approval with a free custom project analysis.